2020 ISPE Facilities of the Future Conference

The 2020 ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future. Featuring technical and inspirational presentations from industry leaders already planning and building “facilities of the future” this conference will look at new manufacturing challenges, technologies, and regulatory factors impacting the ability of today’s companies to stay competitive and cost-effective.

This conference will explore:

  • New and legacy pharmaceutical facilities as both must be efficient and cGMP compliant while adopting emerging technologies to improve drug quality
  • Impact of disruptive technologies and Pharma 4.0
  • Highly automated processes using the Internet of Things (IoT)
  • Artificial Intelligence (AI)
  • Robotics
  • Advanced analytics and machine learning 

This conference will bring together diverse experts to share best practices and benchmark solutions for new and existing facilities. 

Why Attend?

  • Learn how award-winning industry leaders successfully implemented technology innovations in facility design including virtual reality, artificial intelligence and automation
  • Interact with industry and regulatory thought leaders about addressing key issues in pharmaceutical manufacturing facilities today
  • Identify current challenges in facility design and define the “procedures” of the future
  • Learn from industry leaders about their approaches to cyber security, lifecycle engineering and plant asset management for the facility of the future

Who Should Attend?

This conference provides relevant content of interest to all levels of professionals in the pharmaceutical engineering field, especially those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.

Young Professionals Senior Executives Communities of Practice Special Interest Groups Equipment and Services Suppliers Regulatory Professionals

Program Committee Members

James A. Breen, Jr., PE
Vice President, Lead Biologics Expansion
Janssen Pharmaceuticals
Jeffrey A. Biskup, PE
CEO and Chairman of the Board
Gunter Baumgartner
Senior Vice President, Head of Global Engineering
Takeda Pharmaceuticals International AG
Mark A. Butler
President and Managing Director
Austin G. Lock
Technical Director & Deputy Pharmaceutical Sector Director
PM Group
Michael Martin
Global Director, Program & Project Management
Brian K. Vaughn
President, ISPE San Francisco Bay Area Chapter